-
1
MET gene variant linked to steatotic liver disease.
-
2
Study published in Hepatology by Mayo Clinic.
-
3
Disruption in MET signaling affects lipid metabolism.
-
4
1.1% of patients with SLD have rare MET variants.
-
5
First reported nonmalignant MET-driven steatotic liver disease.
-
6
Functional assays confirm variant's impact on liver metabolism.
-
7
Further studies needed for diagnostic implications.
Original Source(s)
Related Content
Deep-Fried Lipidomics
Chemometric analysis identifies lipid markers linked to thermal deterioration of frying oils
March 17, 2026
-
2 min
Women and Liver Fibrosis Risk: New Insights
Study reveals sex-specific differences in fibrosis associations
March 17, 2026
-
3 min
Shining a Light on Microplastic Transport in the Body
NIR-II fluorescent labeling reveals how nanoscale plastic fragments move through the gut
March 16, 2026
-
3 min
